Abstract
Male breast carcinoma shares many similar epidemiologic, genetic, diagnostic, therapeutic, and prognostic factors with breast carcinoma in women. The genetic factor most clearly associated with male breast carcinoma is the BRCA2 germ-line mutation. Other heritable mutations observed in male breast carcinoma include BRCA1, the androgen receptor gene, and the mismatch repair genes associated with Lynch syndrome.